Mod­er­na asks FDA to open the door for 4th Covid shots for all adults

4 years ago
Coronavirus

Mar­tin Shkre­li can't de­lay $25M pay­ment over an­ti­com­pet­i­tive case, judge rules

4 years ago
People

Hot on Roche’s heels, Mer­ck spells out mixed Keytru­da da­ta in ad­ju­vant NSCLC

4 years ago
R&D
Pharma

Zai Lab gives Josh Smi­ley a sec­ond chance in a prime role; De­nali gets ready to re­arrange staff as clin­i­cal hold ...

4 years ago
Peer Review

Phar­ma watch­dog calls out As­traZeneca, Glax­o­SmithK­line for breach­es on on­line con­duct

4 years ago
Pharma

Re­al Chem­istry re­caps ban­ner 2021, sets ‘change agent’ goals mov­ing be­yond Covid-19 pan­dem­ic

4 years ago
Pharma
Marketing

Ac­cel­er­at­ed ap­proval re­forms take cen­ter stage at House hear­ing, but a way for­ward re­mains un­clear

4 years ago
FDA+

Mer­ck KGaA to pay over $3M to pa­tients af­ter drug for­mu­la­tion change-up trig­gered com­plaints

4 years ago
Pharma
Law

Bust­ed in the wake of a CRL, Athenex brings out bud­get axe af­ter 'go­ing con­cern' alert

4 years ago
Deals

Em­broiled in a years-long le­gal saga, CareDx pulls a win over Nat­era in false ad­ver­tis­ing case

4 years ago
Pharma
Law

Two US com­pa­nies ink deals to ex­pand biosim­i­lar of­fer­ings

4 years ago
Pharma
Manufacturing

Q&A: De­ter­mined to not re­peat mis­takes from the last pan­dem­ic, An­drey Zarur talks about lat­est deal with Serum ...

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Ger­many locks in vac­cine sup­ply un­til 2029; White House an­nounces vac­cine do­na­tion ...

4 years ago
Coronavirus
Manufacturing

Man­u­fac­tur­ing roundup: Vec­tor Labs ex­pands in Bay Area; Boul­der biotech en­lists East Coast CD­MO

4 years ago
Manufacturing

Rin­voq nabs new ap­proval in sec­ond-line UC; Sen­so­ri­on says its failed drug now works in sub­set analy­sis

4 years ago
News Briefing

GSK falls in line with Big Phar­ma's re­ac­tion to Ukraine in­va­sion, cut­ting off new clin­i­cal tri­als, do­nat­ing prof­its ...

4 years ago
Pharma

Apel­lis ris­es on long-term da­ta for Soliris chal­lenger af­ter mixed PhI­II read­out, and an­a­lysts are more bull­ish on ...

4 years ago
R&D

A lit­tle biotech crows about its Covid-19 'one and done' PhI­II, caus­ing at least one top an­a­lyst to change his tune ...

4 years ago
R&D
Coronavirus

Al­ny­lam seeks com­pen­sa­tion from Mod­er­na and Pfiz­er in suits over patent­ed de­liv­ery of their Covid-19 vac­cines

4 years ago
Coronavirus
Law

Biden ap­points Brown's pub­lic health school dean as new White House Covid-19 co­or­di­na­tor

4 years ago
People
Coronavirus

Chi­na work­ing on con­ces­sions to help home­grown com­pa­nies stay on US ex­changes — re­port

4 years ago
China
FDA+

Fi­nal AC­TIV-2 en­roll­ment is stopped, leav­ing tiny biotech with­out a sec­ond PhI­II study

4 years ago
R&D
Coronavirus

Bio­gen los­es an­oth­er bid to re­vive Tec­fidera patent as gener­ic keeps eat­ing in­to block­buster sales

4 years ago
Pharma
Law

As­traZeneca shells out $775M to set­tle Ul­tomiris patent suit with Roche

4 years ago
Pharma
Law
First page Previous page 556557558559560561562 Next page Last page
A service from the Financial Times